matt krebs @krebs_matt

Head of @BioCentury 's global new business sales operations. Post news, analysis and events on the biopharma industry. Mostly from https://t.co/BIv0E1aVuB biocentury.com California, USA Joined November 2011

Tweets

4K
Followers

5K
Following

4K
Likes

10K

matt krebs @krebs_matt

2 months ago

linkedin.com/posts/mattkreb…

0 0 2 107 0

matt krebs @krebs_matt

2 months ago

linkedin.com/posts/mattkreb…

0 0 1 119 0

Jessica Adams @RxRegA

a year ago

I'm passionate about FDA advisory committees because if they're done right they're invaluable. I agree w/ this @BioCentury commentary that plans to reform the process have been disappointing. biocentury.com/article/653759… Fwiw I cobbled together a few proposals. x.com/RxRegA/status/…

Jessica Adams @RxRegA

a year ago

3 0 5 2K 1

Download Image

0 2 2 771 0

FDA Oncology @FDAOncology

a year ago

We enjoyed hosting journalist and author Steve Usdin for a lively discussion about his work, regulatory policies, and oncology drug development. Thank you for stopping by @steveusdin1!

0 4 13 3K 0

Download Image

BioCentury @BioCentury

2 years ago

Anti-China bills portend massive blow to biotech. According to a BioCentury survey, an overwhelming majority of biotechs expect pipeline setbacks; many oppose BIO’s reversal buff.ly/4cpmAeW

0 8 13 3K 0

BioCentury @BioCentury

2 years ago

@RepGallagher's impending resignation could take some steam out of the Biosecure Act, but national security concerns about Chinese biotech isn't dissipating buff.ly/3Pz1ykb

0 4 3 1K 3

matt krebs @krebs_matt

2 years ago

I’ve noticed both subscribers and soon-to-be-subscribers checking out this report. DM me or reach out on our website for access. 😎 x.com/BioCentury/sta…

BioCentury @BioCentury

2 years ago

I’ve noticed both subscribers and soon-to-be-subscribers checking out this report. DM me or reach out on our website for access. 😎 x.com/BioCentury/sta…

0 2 3 1K 1

0 0 1 292 0

BioCentury @BioCentury

2 years ago

Private Radiopharma companies favor funding for β- and α-emitting Radioisotopes, exploring next-wave Targets alongside or instead of established SSTR2 and PSMA targets. Access report: #Radiopharmaceuticals’ multi-dimensional next wave: bit.ly/3UHhKTZ #radiopharmacy

0 1 5 862 1

Download Image

BioCentury @BioCentury

2 years ago

Three weeks remain until #biopharma executives and investors gather in Singapore for the 3rd #BioCenturyEastWest Summit. Join us for two days of networking, partnering, and debate on how to build global #biotech ecosystems. Register: ow.ly/hbvj50QE97g

0 1 0 616 0

Download Video

Josh Berlin @BioPharmaJosh

2 years ago

Check out the latest episode of The BioCentury Show w/Khoo Shi, CEO of ClavystBio (@Temasek). Learn: Which global investors are helping #Singapore biotechs tap into global networks and talent. Watch: youtube.com/watch?v=TjNMER… P.S. Want to learn more? BioCenturyEastWest.com

0 2 3 489 0

Download Image

matt krebs @krebs_matt

2 years ago

Can you guess what CAR T therapies for MM are in this graph? Details here @BioCentury : biocentury.com/article/651300 (sub/trial access required)

0 0 2 152 0

Download Image

matt krebs @krebs_matt

2 years ago

What indicators are you looking at for signs of a biotech public market recovery? Post Follow-On Performance on your radars? Check out our "The Year of Biotech's Recovery" analysis here @BioCentury : biocentury.com/article/651069… (trial/sub access required)

0 0 1 146 1

Download Image

matt krebs @krebs_matt

2 years ago

Next-gen gene editing at ASH #ash2024 #ash24 Details and analysis @BioCentury biocentury.com/article/650931…

0 1 2 320 0

Download Image

BioCentury @BioCentury

2 years ago

.@ARPA_H is coming into focus. The agency's first director, Renee Wegrzyn, is creating a plan to achieve things that seem impossible. Wegrzyn speaks with Washington Editor @steveusdin1 on the #BioCenturyShow buff.ly/3t0ydHf

0 2 1 1K 0

matt krebs @krebs_matt

2 years ago

Ever wish you could imagine the pandemic never happened? This is what the world of financing for biotechs looks like without it in @BioCentury Chk out our FREE (with registration) financial dashboard here: biocentury.com/bciq-data/fina… Great way for you to run your own analysis!